基于动作观察治疗的外骨骼(AOT-EXO)用于卒中后上肢康复:随机对照试验研究方案
AOT-EXO试验为多中心、前瞻性、三组随机对照试验,计划在中国武汉三所医院招募132例卒中患者,随机分为常规治疗组、外骨骼治疗组和基于动作观察治疗的外骨骼组。主要结局为FMA-UE,次要结局包括ARAT、MBI、IMU运动学指标、rMT、MEP、fMRI及安全性,评估时间点为基线、干预4周后和随访12周时。
要点
- AOT-EXO试验旨在探究动作观察治疗联合机器人辅助训练能否增强运动环路激活并改善上肢运动结局。
- 计划招募132例卒中患者,随机分为常规治疗、外骨骼治疗和AOT-EXO三组。
- 主要结局为FMA-UE,评估时间点为基线、干预4周后和随访12周时。
核心结论
- 该试验将为AOT-EXO用于卒中后上肢康复的可行性和疗效提供证据,并阐明潜在的运动学和神经机制。
研究设计与样本
- 多中心、前瞻性、三组随机对照试验,计划在华中科技大学同济医院、同济医院光谷院区和湖北省中西医结合医院招募132例卒中患者。
- 纳入患者随机分为常规治疗组、外骨骼治疗组和基于动作观察治疗的外骨骼组。
- 在基线、干预4周后和随访12周时进行盲法评估。
关键数值与推荐
- 主要结局为上肢Fugl-Meyer评估(FMA-UE)。
- 次要结局包括动作研究手臂测试(ARAT)、改良Barthel指数(MBI)、惯性测量单元(IMU)评估的运动学指标、静息运动阈值(rMT)、运动诱发电位(MEP)、功能磁共振成像(fMRI)及安全性结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stroke produces multiple symptoms, including sensory, motor, cognitive and psychological dysfunctions, among which motor deficit is the most common and is widely recognized as a major contributor to long-term functional disability. Robot-assisted training is effective in promoting upper extremity muscle strength and motor impairment recovery after stroke. Additionally, action observation treatment can enhance the effects of physical and occupational therapy by increasing neural activation. The AOT-EXO trial aims to investigate whether action observation treatment coupled with robot-assisted training could enhance motor circuit activation and improve upper extremity motor outcomes. METHODS: The AOT-EXO trial is a multicentre, prospective, three-group randomized controlled trial (RCT). We will screen and enrol 132 eligible patients in the trial implemented in the Department of Rehabilitation Medicine of Tongji Hospital, Optical Valley Branch of Tongji Hospital and Hubei Province Hospital of Integrated Chinese & Western Medicine in Wuhan, China. Prior to study participation, written informed consent will be obtained from eligible patients in accordance with the Declaration of Helsinki. The enrolled stroke patients will be randomized to three groups: the CT group (conventional therapy); EXO group (exoskeleton therapy) and AOT-EXO group (action observation treatment-based exoskeleton therapy). The patients will undergo blinded assessments at baseline, post-intervention (after 4 weeks) and follow-up (after 12 weeks). The primary outcome will be the Fugl-Meyer Assessment for Upper Extremity (FMA-UE). Secondary outcomes will include the Action Research Arm Test (ARAT), modified Barthel Index (MBI), kinematic metrics assessed by inertial measurement unit (IMU), resting motor threshold (rMT), motor evoked potentials (MEP), functional magnetic resonance imaging (fMRI) and safety outcomes. DISCUSSION: This trial will provide evidence regarding the feasibility and efficacy of the action observation treatment-based exoskeleton (AOT-EXO) for post-stroke upper extremity rehabilitation and elucidate the potential underlying kinematic and neurological mechanisms. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1900026656 . Registered on 17 October 2019.
引用
- Chen Z, Xia N, He C, et al. Action observation treatment-based exoskeleton (AOT-EXO) for upper extremity after stroke: study protocol for a randomized controlled trial. Trials. 2021. PMID: 33743788. doi:10.1186/s13063-021-05176-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。